Find clinical trials for Multiple Myeloma in Durham, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Durham, NC, USA:
A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
The purpose of this study is to evaluate three daratumumab dose schedules in participants with Smoldering Multiple Myeloma....
Phase 2
Chapel Hill, North Carolina, United States and 56 other locations
lenalidomide and dexamethasone for the treatment of newly diagnosed multiple myeloma (MM). The study team will use lower doses than...
Phase 2
Durham, North Carolina, United States and 2 other locations
This study is designed as a phase I-II, open label, dose finding study.Study treatment will be as follows, in 28 day cycles:* Pomalidomide: once dail...
Phase 1, Phase 2
Durham, North Carolina, United States
of these combinations in participants with relapsed or refractory multiple myeloma. The study will consist of 3 distinct parts: Par ...
Phase 2
Durham, North Carolina, United States and 40 other locations
A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in...
Phase 2
Durham, North Carolina, United States and 31 other locations
phases, for the treatment of patients with relapsed/refractory multiple myeloma (RRMM) and newly diagnosed multiple myeloma...
Phase 1, Phase 2
Durham, North Carolina, United States and 18 other locations
versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...
Phase 3
Durham, North Carolina, United States and 59 other locations
This study is a first-in-human, Phase 1, open-label study that will evaluate safety and anti-myeloma activity of ISB 2001 in participants wi ...
Phase 1
Chapel Hill, North Carolina, United States and 6 other locations
This is a phase 1, open-label study evaluating the safety, clinical pharmacology and clinical activity of TNB-383B, a BCMA x CD3 T-cell engaging bisp...
Phase 1, Phase 2
Chapel Hill, North Carolina, United States and 13 other locations
versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...
Phase 3
Durham, North Carolina, United States and 126 other locations
Clinical trials
Research sites
Resources
Legal